{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:05:28Z","timestamp":1793397928984,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12022-024-09841-0","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T04:23:46Z","timestamp":1732335826000},"page":"349-353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Multilineage Pituitary Neuroendocrine Tumors Expressing TPIT and SF1: A Clinicopathological Series of Six Tumors"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8418-5054","authenticated-orcid":false,"given":"Sylvia L.","family":"Asa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg H.","family":"Faiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6962-3535","authenticated-orcid":false,"given":"Amr","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0469-2801","authenticated-orcid":false,"given":"Ozgur","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,23]]},"reference":[{"key":"9841_CR1","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/s41379-021-00820-y","volume":"34","author":"SL Asa","year":"2021","unstructured":"Asa SL, Mete O, Cusimano MD, McCutcheon IE, Perry A, Yamada S, Nishioka H, Casar-Borota O, Uccella S, La Rosa S, Grossman AB, Ezzat S: Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification. Mod Pathol 2021, 34:1634-1650.","journal-title":"Mod Pathol"},{"key":"9841_CR2","doi-asserted-by":"crossref","unstructured":"Asa SL, Perry A: Tumors of the Pituitary Gland. Series 5 edition. Arlington VA: ARP Press; (2020)","DOI":"10.55418\/9781933477916"},{"key":"9841_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A, Osamura RY: Overview of the 2022 WHO Classification of Pituitary Tumors. Endocr Pathol 2022, 33:6-26.","journal-title":"Endocr Pathol"},{"issue":"273","key":"9841_CR4","first-page":"278","volume":"34","author":"SL Asa","year":"2023","unstructured":"Asa SL, Mete O, Riddle ND, Perry A: Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1. Endocr Pathol 2023.","journal-title":"Endocr Pathol."},{"key":"9841_CR5","doi-asserted-by":"crossref","unstructured":"Fookeerah P, Varikatt W, Shingde M, Dexter MAJ, McLean M: Somatostatin receptor expression and clinical outcome of multilineage pituitary tumours expressing PIT1 and SF1. Endocr Connect (2023) 12","DOI":"10.1530\/EC-23-0328"},{"key":"9841_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00401-024-02686-1","volume":"147","author":"M Dottermusch","year":"2024","unstructured":"Dottermusch M, Ryba A, Ricklefs FL, Flitsch J, Schmid S, Glatzel M, Saeger W, Neumann JE, Schuller U: Pituitary neuroendocrine tumors with PIT1\/SF1 co-expression show distinct clinicopathological and molecular features. Acta Neuropathol 2024, 147:16.","journal-title":"Acta Neuropathol"},{"key":"9841_CR7","doi-asserted-by":"crossref","unstructured":"Dogukan FM, Karatay H, Yuzkan S, Burhan S, Erkan B, Yilmaz-Ozguven B: Clinicopathological Correlates of PIT1 and SF1-Multilineage Pituitary Neuroendocrine Tumors and the Diagnostic Utility of NKX2.2 Immunohistochemistry in Pituitary Pathology. Arch Pathol Lab Med (2024).","DOI":"10.5858\/arpa.2023-0543-OA"},{"key":"9841_CR8","doi-asserted-by":"crossref","unstructured":"Kleinschmidt-DeMasters BK, Turin CG: Reassessment of Plurihormonal Pituitary Adenomas\/PitNETs. Am J Surg Pathol 2024.","DOI":"10.1097\/PAS.0000000000002306"},{"key":"9841_CR9","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/10668969231183712","volume":"32","author":"M Mihajlovic","year":"2024","unstructured":"Mihajlovic M, Pekic S, Doknic M, Stojanovic M, Rasic D, Miljic D, Petakov M, Manojlovic GE: Plurihormonal Pituitary Neuroendocrine Tumours - A Single Centre Experience. Int J Surg Pathol 2024, 32:470-477.","journal-title":"Int J Surg Pathol"},{"key":"9841_CR10","doi-asserted-by":"crossref","unstructured":"Wang X, Tang H, Bie Z, Wang Y, Yuan R, Zhang Z, Xiong Z, Yang Z, Bi Z, Wang B, Liu P: Clinical and Pathological Features of Pit1\/SF1 Multilineage Pituitary Neuroendocrine Tumor. Neurosurgery 2024.","DOI":"10.1227\/neu.0000000000002846"},{"key":"9841_CR11","doi-asserted-by":"crossref","unstructured":"Zhang Y, Tang H, Li S, Bie Z, Ma X, Wu H, Liu G, Wang X, Liu P, Yang Z: Co-expression of multiple transcription factors is associated with clinical features and endocrine prognosis in growth hormone-secreting pituitary adenomas. Endocrine (2024)","DOI":"10.1007\/s12020-024-04082-x"},{"key":"9841_CR12","doi-asserted-by":"crossref","unstructured":"Bove I, Cheok SK, Feng JJ, Briggs RG, Ruzevick J, Cote DJ, Shah I, Little A, Laws E, Castro AV, Carmichael J, Shiroishi M, Hurth K, Zada G: Clinical implications of pituitary adenomas exhibiting dual transcription factor staining: A case series of 27 patients. World Neurosurg 2023.","DOI":"10.1016\/j.wneu.2023.11.036"},{"key":"9841_CR13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s12022-018-9545-4","volume":"29","author":"O Mete","year":"2018","unstructured":"Mete O, Alshaikh OM, Cintosun A, Ezzat S, Asa SL: Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages. Endocr Pathol 2018, 29:332-338.","journal-title":"Endocr Pathol"},{"key":"9841_CR14","doi-asserted-by":"crossref","unstructured":"Asa SL, Mohamed A: Pancreatic and Ileal Neuroendocrine Tumors: Metastatic Disease or a Novel MEN Syndrome? Am J Surg Pathol 2024.","DOI":"10.1097\/PAS.0000000000002290"},{"key":"9841_CR15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/000124545","volume":"43","author":"SL Asa","year":"1986","unstructured":"Asa SL, Kovacs K, Laszlo FA, Domokos I, Ezrin C: Human fetal adenohypophysis. Histologic and immunocytochemical analysis. Neuroendocrinology 1986, 43:308-316.","journal-title":"Histologic and immunocytochemical analysis. Neuroendocrinol"},{"issue":"Pt 1","key":"9841_CR16","first-page":"275","volume":"19","author":"SL Asa","year":"1984","unstructured":"Asa SL, Kovacs K: Functional morphology of the human fetal pituitary. Pathology Annual 1984, 19 Pt 1:275-315.","journal-title":"Pathology Annual"},{"key":"9841_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1159\/000125044","volume":"48","author":"SL Asa","year":"1988","unstructured":"Asa SL, Kovacs K, Horvath E, Losinski NE, Laszlo FA, Domokos I, Halliday WC: Human fetal adenohypophysis. Electron microscopic and ultrastructural immunocytochemical analysis. Neuroendocrinology 1988, 48:423-431.","journal-title":"Neuroendocrinology"},{"key":"9841_CR18","first-page":"2021","volume":"80","author":"A-M Bamberger","year":"1995","unstructured":"Bamberger A-M, Bamberger CM, Pu L-P, Puy LA, Loh YP, Asa SL: Expression of pit-1 messenger ribonucleic acid and protein in the human placenta. J Clin Endocrinol Metab 1995, 80:2021-2026.","journal-title":"J Clin Endocrinol Metab"},{"key":"9841_CR19","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1101\/gad.8.19.2302","volume":"8","author":"HA Ingraham","year":"1994","unstructured":"Ingraham HA, Lala DS, Ikeda Y, Luo X, Shen W-H, Nachtigal MW, Abbud R, Nilson JH, Parker KL: The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev 1994, 8:2302-2312.","journal-title":"Genes Dev"},{"key":"9841_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/molehr\/2.6.457","volume":"2","author":"AM Bamberger","year":"1996","unstructured":"Bamberger AM, Ezzat S, Cao B, Wong M, Parker KL, Schulte HM, Asa SL: Expression of steroidogenic factor-1 (SF-1) mRNA and protein in the human placenta. Mol Hum Reprod 1996, 2:457-461.","journal-title":"Mol Hum Reprod"},{"key":"9841_CR21","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41379-018-0167-7","volume":"32","author":"O Mete","year":"2019","unstructured":"Mete O, Kefeli M, Caliskan S, Asa SL: GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors. Mod Pathol 2019, 32:484-489.","journal-title":"Mod Pathol"},{"key":"9841_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s12022-020-09646-x","volume":"31","author":"O Mete","year":"2020","unstructured":"Mete O, Asa SL: Structure, Function, and Morphology in the Classification of Pituitary Neuroendocrine Tumors: the Importance of Routine Analysis of Pituitary Transcription Factors. Endocr Pathol 2020, 31:330-336.","journal-title":"Endocr Pathol"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-024-09841-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-024-09841-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-024-09841-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T18:10:24Z","timestamp":1734631824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-024-09841-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,23]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9841"],"URL":"https:\/\/doi.org\/10.1007\/s12022-024-09841-0","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,23]]},"assertion":[{"value":"17 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Obtained from both institutions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Dr. Sylvia L. Asa is a member of the Editorial Board of Endocrine Pathology. Dr. Ozgur Mete is the Editor-in-Chief of Endocrine Pathology. This article is handled by an independent Editor as per Springer Nature policies. All remaining authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}